Search

everythinglearnresearchcommunity

for

Search:↓

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some cancer treatments can cause permanent hair loss.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Better supportive care is needed to manage chemotherapy side effects.

People undergoing chemotherapy need better support and information to cope with hair loss.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.